Survey of current practice for prevention of transfusion-transmitted cytomegalovirus in the United States: Leucoreduction vs. cytomegalovirus- seronegative

Vox Sanguinis

Volumn 98, Issue 1, 2010, Pages 29-36

  Smith, D ^a   Lu, Q ^a   Yuan, S ^a   Goldfinger, D ^a   Fernando, L P ^b   Ziman, A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CMV; Leucoreduction; Survey; Transfusion transmitted

Indexed keywords

ARTICLE; BLOOD BANK; BLOOD TRANSFUSION; COMMUNITY HOSPITAL; CYTOMEGALOVIRUS; LEUCOREDUCTION; LEUKAPHERESIS; PATIENT SAFETY; PRIORITY JOURNAL; RISK REDUCTION; UNITED STATES; UNIVERSITY HOSPITAL; VIRUS TRANSMISSION;

AGE FACTORS; BLOOD BANKS; BLOOD TRANSFUSION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DATA COLLECTION; HEALTH FACILITIES; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; PHYSICIAN'S PRACTICE PATTERNS; SEROLOGIC TESTS; UNITED STATES;

EID: 73649145150     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2009.01228.x     Document Type: Article

References (29)

1. Adler SP. : Transfusion-associated cytomegalovirus infections. Rev Infect Dis 1983 5 : 977 993
2. Tegtmeier GE : Transfusion-transmitted cytomegalovirus infections: significance and control. Vox Sang 1986 51 (Suppl 1 22 30
3. Pass RF : Cytomegalovirus in Knipe DM, Howley PM (eds Fields Virology. Philadelphia, Lippincott-Williams and Wilkins, 2001 : 2675 2705
4. Sissons JG, Bain M, Wills MR : Latency and reactivation of human cytomegalovirus. J Infect 2002 44 : 73 77 314-21
5. Yeager AS, Grumet FC, Hafleigh EB, Arvin AM, Bradley JS, Prober CG : Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr 1981 98 : 281 287
6. Bowden RA, Sayers M, Flournoy N, Newton B, Banaji M, Thomas ED, Meyers JD : Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 1986 314 : 1006 1010
7. Bowden RA, Sayers M, Gleaves CA, Banaji M, Newton B, Meyers JD : Cytomegalovirus-seronegative blood components for the prevention of primary cytomegalovirus infection after marrow transplantation. Considerations for blood banks. Transfusion 1987 27 : 478 481
8. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ : Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006 43 : 1143 1151
9. Roback JD : Human herpesvirus infections in Hillyer CD, Silberstein LE, Ness PM Anderson KC (eds Human Herpesvirus Infections. Blood Banking and Transfusion Medicine: Basic Principles & Practice. Philadelphia, Churchill Livingstone, 2003 : 465 485
10. Goldfinger D, Lowe C : A critical analysis of saline washed red blood cells with special reference to their ability to prevent adverse reactions to blood transfusion. In : Polesky HF, Walker RH (eds Safety in Transfusion Practices. Skokie, IL, College of American Pathologists, 1982 : 205 222
11. Eisenfeld L, Silver H, McLaughlin J, Klevjer-Anderson P, Mayo D, Anderson J, Herson V, Krause P, Savidakis J, Lazar A : Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood. Transfusion 1992 32 : 205 209
12. Gilbert GL, Hayes K, Hudson IL, James J : Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group. Lancet 1989 1 : 1228 1231
13. Verdock LF, de Graan-Hentzen YC, Dekker AW, Mudde GC, de Gast GC : Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation. Bone Marrow Transplant 1987 2 : 73 78
14. de Graan-Hentzen YC, Gratama JW, Mudde GC, Verdonck LF, Houbiers JG, Brand A, Sebens FW, van Loon AM, The TH, Willemze R, de Gast GC : Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products. Transfusion 1989 29 : 757 760
15. De Witte T, Schattenberg A, Van Dijk BA, Galama J, Olthuis H, Van der Meer JW, Kunst VA : Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood products from cytomegalovirus-unscreened blood-bank donors. Transplantation 1990 50 : 964 968
16. Hillyer CD, Emmens RK, Zago-Novaretti M, Berkman EM : Methods for the reduction of transfusion-transmitted cytomegalovirus infection: filtration versus the use of seronegative donor units. Transfusion 1994 34 : 929 934
17. Bowden RA, Slichter SJ, Sayers M, Weisdorf D, Cays M, Schoch G, Banaji M, Haake R, Welk K, Fisher L, McCullough J, Miller W : A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplantation. Blood 1995 86 : 3598 3607
18. American Association of Blood Banks : Leukocyte Reduction for the Prevention of Transfusion - Transmitted Cytomegalovirus (TT-CMV). Bethesda, MD, American Association of Blood Banks Association Bulletin 97-2; April 23, 1997
19. Laupacis A, Brown J, Costello B, Delage G, Freedman J, Hume H, King S, Kleinman S, Mazzulli T, Wells G : Prevention of posttransfusion CMV in the era of universal WBC reduction: a consensus statement. Transfusion. 2001 41 : 560 569 (Pubitemid 32378113)
20. Blajchman MA, Goldman M, Freedman JJ, Sher GD : Proceedings of a consensus conference: prevention of post-transfusion CMV in the era of universal leukoreduction. Transfus Med Rev 2001 15 : 1 20
21. Landaw EM, Kanter M, Petz LD : Safety of filtered leukocyte-reduced blood products for prevention of transfusion-associated cytomegalovirus infection. (Letter) Blood 1996 87 : 4910
22. Nichols WG, Price TH, Gooley T, Corey L, Boeckh M : Transfusion- transmitted cytomegalovirus infection after receipt of leukoreduced blood products. Blood 2003 101 : 4195 4200
23. Vamvakas EC : Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis. Transfus Med Rev 2005 19 : 181 199
24. Ziemann M, Krueger S, Maier AB, Unmack A, Goerg S, Hennig H : High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion. Transfusion 2007 47 : 1972 1983
25. Drew WL, Roback JD : Prevention of transfusion-transmitted cytomegalovirus: reactivation of the debate? (Editorial). Transfusion 2007 47 : 1955 1958
26. Winston DJ, Ho WG, Champlin RE : Current approaches to management of infections in bone marrow transplants. Eur J Cancer Clin Oncol 1989 25 (Suppl 2 S25 S35
27. Sayers M, Anderson K, Goodnough L, Kurtz SR, Lane TA, Pisciotto P, Silberstein LE : Reducing the risk for transfusion-transmitted cytomegalovirus infection. Ann Intern Med 1992 116 : 55
28. Boeckh M, Leisenring W, Riddell SR, Bowden RA, Huang ML, Myerson D, Stevens-Ayers T, Flowers MED, Cunningham T, Corey L : Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 2003 101 : 407 414
29. Torres-Madriz G, Boucher HW : Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients. Clin Infect Dis 2008 47 : 702 711